tiprankstipranks
Trending News
More News >
China Medical System Holdings Ltd. (HK:0867)
:0867
Hong Kong Market

China Medical System Holdings (0867) Ratios

Compare
3 Followers

China Medical System Holdings Ratios

HK:0867's free cash flow for Q4 2024 was ¥0.00. For the 2024 fiscal year, HK:0867's free cash flow was decreased by ¥ and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.74 4.29 3.07 3.55 5.46
Quick Ratio
5.24 3.98 2.90 3.32 5.04
Cash Ratio
2.44 2.10 1.52 1.63 2.93
Solvency Ratio
1.14 1.20 1.16 1.09 1.71
Operating Cash Flow Ratio
0.84 1.22 1.24 1.20 2.95
Short-Term Operating Cash Flow Coverage
1.53 1.97 1.99 2.26 269.20K
Net Current Asset Value
¥ 7.06B¥ 6.62B¥ 5.81B¥ 4.42B¥ 3.38B
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.07 0.10 0.11 0.05
Debt-to-Equity Ratio
0.05 0.08 0.12 0.13 0.05
Debt-to-Capital Ratio
0.05 0.08 0.11 0.12 0.05
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.04 0.05
Financial Leverage Ratio
1.11 1.14 1.22 1.24 1.15
Debt Service Coverage Ratio
2.20 1.85 1.84 2.89 101.40
Interest Coverage Ratio
44.87 58.65 81.91 136.75 119.25
Debt to Market Cap
0.05 0.04 0.07 0.06 0.03
Interest Debt Per Share
0.37 0.55 0.76 0.71 0.25
Net Debt to EBITDA
-1.23 -1.03 -0.67 -0.45 -0.68
Profitability Margins
Gross Profit Margin
72.60%76.24%76.89%74.93%73.92%
EBIT Margin
27.43%33.85%41.66%41.80%40.94%
EBITDA Margin
30.90%36.47%42.07%44.44%43.94%
Operating Profit Margin
23.20%33.85%43.94%46.37%47.25%
Pretax Profit Margin
26.92%35.86%41.12%41.46%40.54%
Net Profit Margin
21.69%29.96%35.62%36.19%36.43%
Continuous Operations Profit Margin
21.60%29.76%35.80%36.29%36.79%
Net Income Per EBT
80.57%83.55%86.61%87.29%89.86%
EBT Per EBIT
116.03%105.93%93.59%89.41%85.81%
Return on Assets (ROA)
8.97%13.54%18.36%19.09%19.92%
Return on Equity (ROE)
9.93%15.47%22.34%23.66%22.93%
Return on Capital Employed (ROCE)
10.48%17.30%27.03%28.16%27.84%
Return on Invested Capital (ROIC)
8.00%13.27%20.99%22.79%25.25%
Return on Tangible Assets
12.45%17.19%25.59%27.16%29.36%
Earnings Yield
9.41%7.92%12.25%11.53%14.05%
Efficiency Ratios
Receivables Turnover
4.02 4.62 4.49 3.84 4.08
Payables Turnover
14.37 13.44 11.88 14.33 13.44
Inventory Turnover
2.66 2.99 4.43 4.42 4.75
Fixed Asset Turnover
16.67 16.91 18.47 15.30 13.06
Asset Turnover
0.41 0.45 0.52 0.53 0.55
Working Capital Turnover Ratio
1.07 1.26 1.63 1.78 2.29
Cash Conversion Cycle
202.47 174.14 133.01 152.01 139.04
Days of Sales Outstanding
90.89 79.07 81.36 94.97 89.40
Days of Inventory Outstanding
136.98 122.23 82.37 82.52 76.80
Days of Payables Outstanding
25.40 27.16 30.73 25.48 27.16
Operating Cycle
227.87 201.30 163.74 177.49 166.20
Cash Flow Ratios
Operating Cash Flow Per Share
0.52 1.02 1.45 1.01 1.09
Free Cash Flow Per Share
0.33 0.89 1.23 0.94 0.95
CapEx Per Share
0.19 0.13 0.21 0.07 0.14
Free Cash Flow to Operating Cash Flow
0.64 0.87 0.85 0.93 0.87
Dividend Paid and CapEx Coverage Ratio
1.25 1.49 1.97 1.86 2.29
Capital Expenditure Coverage Ratio
2.78 7.87 6.77 13.49 7.88
Operating Cash Flow Coverage Ratio
1.47 1.92 1.96 1.46 4.49
Operating Cash Flow to Sales Ratio
0.17 0.31 0.39 0.30 0.39
Free Cash Flow Yield
4.72%7.21%11.38%8.82%13.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.63 12.62 8.16 8.67 7.12
Price-to-Sales (P/S) Ratio
2.30 3.78 2.91 3.14 2.59
Price-to-Book (P/B) Ratio
1.06 1.95 1.82 2.05 1.63
Price-to-Free Cash Flow (P/FCF) Ratio
21.18 13.87 8.79 11.33 7.66
Price-to-Operating Cash Flow Ratio
13.57 12.11 7.49 10.49 6.69
Price-to-Earnings Growth (PEG) Ratio
-0.34 -0.48 0.91 0.44 0.24
Price-to-Fair Value
1.06 1.95 1.82 2.05 1.63
Enterprise Value Multiple
6.22 9.34 6.25 6.61 5.22
Enterprise Value
14.37B 27.30B 24.04B 24.49B 15.94B
EV to EBITDA
6.22 9.34 6.25 6.61 5.22
EV to Sales
1.92 3.41 2.63 2.94 2.29
EV to Free Cash Flow
17.68 12.49 7.94 10.61 6.78
EV to Operating Cash Flow
11.33 10.91 6.77 9.82 5.92
Tangible Book Value Per Share
4.68 4.81 3.96 3.30 2.84
Shareholders’ Equity Per Share
6.72 6.33 5.95 5.17 4.46
Tax and Other Ratios
Effective Tax Rate
0.20 0.17 0.13 0.12 0.09
Revenue Per Share
3.08 3.27 3.73 3.38 2.81
Net Income Per Share
0.67 0.98 1.33 1.22 1.02
Tax Burden
0.81 0.84 0.87 0.87 0.90
Interest Burden
0.98 1.06 0.99 0.99 0.99
Research & Development to Revenue
0.04 0.02 0.01 0.01 <0.01
SG&A to Revenue
0.10 0.08 0.07 0.05 0.04
Stock-Based Compensation to Revenue
0.00 >-0.01 <0.01 <0.01 0.00
Income Quality
0.63 0.87 0.94 0.72 0.96
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis